Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro
Year of publication
2020
Authors
MA Alamri; Tahir ul Qamar M; MU Mirza; R Bhadane; SM Alqahtani; I Muneer; M Froeyen; Outi Salo-Ahen
Organizations and authors
Publication type
Publication format
Article
Parent publication type
Journal
Article type
Data article
Audience
ScientificPeer-reviewed
Peer-ReviewedMINEDU's publication type classification code
A1 Journal article (refereed), original researchPublication channel information
ISSN
Publication forum
Publication forum level
1
Open access
Open access in the publisher’s service
No
Self-archived
Yes
Other information
Fields of science
Chemical sciences; Pharmacy; Biochemistry, cell and molecular biology; Plant biology, microbiology, virology
Keywords
[object Object],[object Object],[object Object],[object Object],[object Object]
Internationality of the publisher
International
Language
English
International co-publication
Yes
Co-publication with a company
No
DOI
10.1080/07391102.2020.1782768
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes